Additionally, differences in CCL2 levels in serum or CSF have been associated with different clinical subtypes of PD.230 Overall, CD163+ and CCR2+ monocytes appear to contribute to neurodegeneration in PD both through peripheral actions and infiltrating the brain. This evidence concerns the gene CCL2 and Parkinson disease.